CLAIRE DIAMANT-YEFET: Open Payments
NPI 1699214551 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,224 in 42 payments from 13 companies in 2025. Trend: 2023 $977 · 2024 $729 · 2025 $1,224
Food & beverage: $1,224
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $719 |
| REVANCE THERAPEUTICS, INC. | 1 | $147 |
| Novo Nordisk Inc | 3 | $57 |
| Galderma Laboratories, L.P. | 2 | $52 |
| PFIZER INC. | 2 | $50 |
| Exact Sciences Corporation | 2 | $39 |
| Lilly USA, LLC | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: VRAYLAR, BOTOX, DAXXIFY, Cologuard Collection Kit, FANAPT, NURTEC ODT, PREVNAR 20, SPRAVATO.
Industry payments across CO — which companies pay providers there.
